Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-015780-14Phase 4Completed
Phase 4, randomised trial of remifentanil in experimental pain, sponsored by Medical University of Vienna. Primary endpoint: Area of pin prick hyperalgesia. Started Nov 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-015780-14.